A B S T R A C T We have explored the possibility of using cultured lymphoblasts from patients with a deficiency of hypoxanthine-guanine phosphoribosyltransferase (HPRT) as a source of cells for the isolation and characterization of mutant forms of the enzyme. HPRT from lymphoblasts derived from six male patients of five unrelated HPRT-deficient families was highly purified and characterized with regard to: (a) level of immunoreactive protein, (b) absolute specific activity, (c) isoelectric point, (d) migration during nondenaturing polyacrylamide gel electrophoresis, and (e) apparent subunit molecular weight. These experiments were performed on small quantities of lymphoblasts using several micromethods involving protein blot analysis of crude extracts as well as isolation and characterization of enzyme labeled in culture with radioactive amino acids. The lymphoblast enzymes from four of the patients exhibited structural and functional abnormalities that were similar to the recently described abnormalities found with the highly purified erythrocyte enzymes from these same patients. In addition, a previously undescribed HPRT variant was isolated and characterized from lymphoblasts derived from two male siblings. This unique variant has been called HPRTA,nn Arbor We conclude that lymphoblastoid cell lines can be used as a source of cells for the detection, isolation, and characterization of structural variants of human HPRT.
INTRODUCTION
Detailed studies on the structure and function of enzyme variants in man have been limited to the more abundant erythrocyte-or plasma-borne enzymes such as glucose-6-phosphate dehydrogenase (1), phosphoglycerate kinase (2) , and carbonic anhydrase (3) . Similar studies on mutant forms of the many other less abundant human intracellular enzymes have been unsuccessful because of the extreme difficulty in purifying the products of the mutant alleles in quantities necessary for detailed analyses.
An important factor limiting the isolation and characterization of mutant human enzymes is the absence of sufficient tissue that expresses the enzyme of interest. An easily accessible human tissue that has been shown to express many different intracellular enzymes is the cultured fibroblast. Indeed, at least 35 inborn errors of metabolism have been demonstrated in cultured fibroblasts (4) . Fibroblasts have not proven useful, however, as a source for the isolation of normal and mutant gene products because of their finite life span and early senescence.
The establishment of permanent lymphoblastoid cell lines from human peripheral blood B lymphocytes by viral transformation provides a potentially useful new model system for the study of the genetic mechanisms responsible for inborn errors of metabolism in man. Lymphoblastoid cells appear to be ideal for genetic and biochemical studies because of their unlimited life span and relatively stable phenotype (5). Fujii et al. (6) have, in fact, recently isolated a mutant form of phosphoglycerate kinase from lymphoblasts derived from a patient with a deficiency of the enzyme. In this report, we have studied the relative expression and structure of hypoxanthine-guanine phosphoribosyl-transferase (HPRT)' in lymphoblasts derived from patients with a deficiency of the enzyme.
HPRT is an intracellular enzyme found in many tissues (7) . It is normally expressed at very low levels as compared with the more abundant intracellular proteins. A complete deficiency of this X-linked enzyme is associated with the Lesch-Nyhan syndrome (8) , while a partial deficiency of enzyme activity is found in some male patients suffering from a severe form of gout (9) . Earlier attemxpts at characterizing the HPRT protein in patients with a deficiency of enzyme activity were mainly limited to the study of the residual enzyme activity in crude hemolysates (cf. 10). As a result, little was learned about the specific mechanisms responsible for a deficiency of HPRT in man.
We have recently succeeded in purifying HPRT from large quantities of erythrocytes from five unrelated male patients with a deficiency of enzyme activity (11) . Detailed study of the structure and function of the highly purified enzymes from these patients indicates that at least four of the enzymes are unique structural variants. Three variants, HPRTToronto, HPRTL.nd.n, and HPRTMUfni,h, were from patients presenting with gout while HPRTKinSton was isolated from a patient with the Lesch-Nyhan syndrome.
Lymphoblastoid cells derived from patients with a deficiency of HPRT would indeed provide many theoretical advantages over erythrocytes as a source of tissue for the study of the genetic mechanism(s) responsible for the deficiency state. Lymphoblasts could be used as a endless source of tissue for the isolation and characterization of normal and mutant forms of the HPRT gene, messenger RNA (mRNA), and protein. In addition, since lymphoblasts are actively dividing and metabolizing cells, they should be amenable to the study of the dynamic processes involved in normal and abnormal expression of the HPRT gene (i.e., mRNA and protein synthesis, processing, and degradation).
We have established permanent lymphoblastoid cell lines from a variety of different HPRT-deficient patients and have developed the methodology necessary to study the structure and function of mutant forms of HPRT from small quantities of lymphoblastoid cells. HPRT was isolated and characterized using lymphoblasts from patients with the previously described erythrocyte enzyme variants: HPRTToronto, HPRTLondon, HPRTKin,ton, and HPRTMunich. Using Establishment and maintenance of lymphoblastoid cell lines. Fresh blood samples (20 ml) from the HPRT-deficient patients were anticoagulated with preservative-free heparin and diluted with an equal volume of buffer A (8.1 mM Na2HPO4, 0.62 mM KH2PO4, pH 7.4 containing 0.14 M NaCl, 2.7 mM KCI, and 1 g/liter glucose). The lymphocytes were isolated by centrifugation in a Ficoll type F-P gradient. The lymphocyte fraction was diluted with 7 ml of medium A (RPMI including 10% fetal bovine serum, 100 U/ml penicillin, and 100 Ag/ml streptomycin), centrifuged at 265 g for 5 min, and washed four times with medium A (10 ml). The cells were resuspended in medium A (5 ml) containing rehydrated phytohemagglutinin (0.1 ml) and placed in the Human Hypoxanthine-Guanine Phosphoribosyltransferase incubator for 72 h. After the phytohemagglutinin stimulation the cells were harvested by centrifugation, resuspended in medium A (5 ml) containing 100,000 U of B95-8 EpsteinBarr virus and placed in a 370C water bath for 1 h. The culture was supplemented with 4 ml of medium A and transferred to the incubator. Transformants began to appear after 2-3 wk.
Two lymphoblastoid cell lines derived from normal males (MGL-8 and GM 130) and one mutagen-induced, HPRTdeficient lymphoblastoid cell line (GM 467) were obtained from the Human Mutant Cell Repository, Camden, N. J. The normal lymphoblastoid cell line, WI-L2, from another normal male was kindly provided by Dr. J. E. Seegmiller, La Jolla, Calif.
Each lymphoblast culture was maintained in medium B (RPMI containing 10% horse serum) at 37°C in the presence of 5% CO2. All media was supplemented with fresh glutamine (2 mM final concentration) immediately before use.
Preparation of lymphoblast extracts. Exponentially growing lymphoblast cultures were harvested and washed with buffer A. The cells were resuspended in a small volume of 10 mM Tris-HCl, pH 7.4, containing 154 mM NaCl (107 cells/250 Al) and lysed by six consecutive freeze-thaw cycles.
Membrane-free extracts were obtained by centrifuging the cell lysates at 100,000 g for 30 min in a Beckman Airfuge (Beckman Instruments, Inc., Spinco Div., Palo Alto, Calif.).
Enzyme assays. HPRT was assayed for enzyme activity by a previously described radiochemical method (22) . Enzyme assays were performed in the presence of either normal or elevated concentrations of the substrates hypoxanthine and 5-phosphoribosyl-1-pyrophosphate (PP-ribose-P) as described previously (11) . 1 U of enzyme activity is defined as the formation of 1 Mmol of inosine monophosphate/min. Protein was assayed according to the method of Lowry et al. (23) using bovine serum albumin as the standard.
Lymphoblast HPRT immunoreactive protein was measured using a previously described radioimmunoassay (11) . The radioimmunoassay is based on the competition of nonradioactive HPRT with 125I-labeled HPRT for binding to HPRT antibody. The least detectable dose of the assay was 0.01 ng based on a 50-Ml sample and the slope of the standard curve was -1.03±0.05 (mean±1 SD, n = 5). Identical slopes were obtained when dilutions of the lymphoblast extracts were used to compete with the 125I-labeled HPRT for binding to the antibody, indicating that the lymphoblast enzymes and the HPRT standard bind to the antibody with the same affinity.
Preparation of insoluble anti-HPR T immunocomplex. HPRT was immunoprecipitated from lymphoblast extract with a preformed rabbit anti-HPRT, goat anti-rabbit immunocomplex. This immunocomplex was made by mixing 1.48 ml of goat anti-rabbit antibody (2.8 mg/ml), 0.36 ml of unfractionated, decomplemented, rabbit antiserum, and 2.63 ml of buffer B (25 mM Tris-HCI containing 154 mM NaCI and 0.02% sodium azide). The mixture was incubated at 37°C for 15 min and 4°C for 12 h. The precipitated complex was recovered by centrifugation at 400 g for 2 min and was washed four times with buffer B (5 ml). The washed immunocomplex was resuspended in 4.5 ml of buffer B and stored at 4°C for up to 6 mo without loss of binding capacity.
Labeling and purification of lymphoblast HPRT. Lymphoblasts from a normal male subject (MGL-8) and from patients G.S., L.P., and I.V. (10 ml; 106 cells/ml) were labeled with [35S]methionine for 14 h in methionine-free RPMI medium containing horse serum (10%), penicillin (100 U/ ml), streptomycin (100 Ag/ml), and [35S]methionine (40 ACi/ ml, 1.1 Ci/Amol). Membrane-free extracts of the labeled cells were obtained as described above. The extracts were supplemented with PP-ribose-P and MgCI2 (final concentrations equal to 20 and 60 mM, respectively) and heated at 85°C for 15 min. The denatured proteins were removed by filtration over a 0.45-MM Millipore filter. HPRT recovered in the filtrate was further purified by immunoprecipitation with the anti-HPRT immunocomplex. The filtrate (-500 ,l) was mixed with an equal volume of protein extract derived from the HPRT-deficient cell line GM 467 (10 mg/ml) and incubated at 370C for 30 min. An aliquot of the anti-HPRT immunocomplex was added (20 ,l) and the mixture was rotated overnight at 4°C. The immunoprecipitate was recovered by centrifugation at 400g for 2 min and was washed once with 0.8 ml of buffer B containing bovine serum albumin (1 mg/ml) and four times with 0.8 ml of buffer C (25 mM Tris-HCl containing 7.5 mM MgCl2, 500 mM NaCl, and 1% Triton).
HPRT in lymphoblasts from E.S. and T.C. was labeled and partially purified using a modified version of the procedure described above. The heat step at 85°C was omitted because the enzyme from E.S. and T.C. was heat labile (data not shown). The labeled protein extracts were directly immunoprecipitated using the procedure described above.
Polyacrylamide gel electrophoresis. Samples were prepared and electrophoresed in 12.5% polyacrylamide gels containing 0.33% N,N'-methylenebisacrylamide in the presence of SDS according to the method of Laemmli (24) .
The lymphoblast extracts were also fractionated in polyacrylamide slab gels under nondenaturing conditions. The nondenaturing gels were prepared and run according to the method of Laemmli except that SDS was excluded from the buffers. The gels contained 6% acrylamide and 0.16% N,N'-methylenebisacrylamide.
Isoelectric focusing. Isoelectric focusing was performed under nondenaturing conditions in polyacrylamide slab gels (2 mm X 9.5 cm X 11 cm) containing 6.0% acrylamide, 0.16% N,N'-methylenebisacrylamide, 5% glycerol, and 5% ampholites (LKB, pH 3.5-10.0). Samples were prepared for focusing by the method of Johnson et al. (25) . The gels were focused as described previously (11) .
HPRT activity stain. HPRT was assayed for enzyme activity in situ after polyacrylamide gel electrophoresis, using a modification of the procedure of Zannis et al. (26) . The only difference between the two methods was the composition of the reaction mixture. The reaction mixture used in our experiments contained 100 mM Tris-HCl, pH 7.4, plus 10 mM MgCl2, 10 mM PP-ribose-P, and 36 MM ['4C]hypoxanthine (55 mCi/mmol).
Protein blot analysis. HPRT immunoreactive protein in lymphoblast extracts was detected after isoelectric focusing or nondenaturing polyacrylamide gel electrophoresis using the protein blot technique. Proteins were transferred from polyacrylamide slab gels to nitrocellulose paper using the procedure of Towbin et al. (27) . After electrophoretic transfer, the blot (nitrocellulose paper with immobilized lymphoblast proteins) was incubated in 20 ml of buffer D (10 mM Tris-HCI, pH 7.4, containing 154 mM NaCl, 3% bovine serum albumin, and 0.02% sodium azide) overnight. The protein blot was then soaked for 4 h with shaking in 20 ml of buffer D containing a 1:500 dilution of HPRT antiserum followed by four 100-ml washes with buffer B. The protein blot was then incubated with 20 ml of buffer D containing 125I-labeled protein A (20,000 cpm/ml) for an additional 4 h with shaking. The nitrocellulose paper was washed and air dried and the labeled immunocomplex was visualized by autoradiography at -70°C with X-OMAT R x-ray film for 24-72 h. Percentage of the average value for the three normal cell lines. Mean±1 SD, (n) = number of determinations. § Calculated absolute specific activity±the SD resulting from the propagation of the errors in the numerator (specific activity) and denominator (CRM level). I Average value for the three normal cell lines.
Results when assayed in the presence of elevated concentrations of substrates as described in Methods.
RESULTS HPRT enzyme activity. The levels of enzyme activity and immunoreactive protein in lymphoblast lysates derived from three unrelated normal male subjects and from the six HPRT deficient patients are summarized in Table I . HPRT enzyme activity was measured in the presence of substrate concentrations that were saturating for the normal enzyme. The level of enzyme activity in lymphoblasts derived from the HPRT-deficient patients was, in each case, lower than the lowest normal value. The specific activity of HPRT from the normal controls and from patients L.P. and G.S. was unchanged when measured in the presence of concentrations of substrates which were higher than normally used (see Methods). Lymphoblasts fromn T.C., K.C., and I.V. exhibited slightly increased specific enzyme activities (-1.2-1.8-fold higher) when measured at these higher substrate concentrations. A more dramatic increase in the level of enzyme activity from 0.05 to 7.73 mU/mg, however, was measured in extracts from patient E.S. when assayed in the presence of higher concentrations of substrates.
HPRT immunoreactivity and absolute specific activity. HPRT immunoreactive protein was quantitated using a previously described radioimmunoassay (11) and the absolute specific activity of the enzyme was calculated from assays of enzyme activity and immunoreactive protein (Table I ). The absolute specific activity of HPRT in the normal lymphoblastoid cell lines2 (44±3 mU/,ug immunoreactive protein, CRM) agrees very well with the previously reported absolute specific activity of HPRT in normal hemolysates, 38±+ mU/jAg CRM (11) , and the specific activity of the highly purified normal erythrocyte enzyme, 36±4 mU/,ug protein (11) . The level of HPRT immunoreactive protein in the HPRT-defic;ent lymphoblasts ranged from 11% of the average control value (T.C. and K.C.) to near normal levels (I.V. and E.S.). The absolute specific activity of HPRT was markedly reduced in lymphoblasts from E.S. (0.3% of control) and I.V. (3% of control). However, the absolute specific activity of HPRT from E.S. was increased to 73% of normal when calculated from activity assays performed in the presence of higher concentrations of substrates.
Isoelectric focusing of lymphoblast HPRT. Lymphoblast extracts were focused in polyacrylamide gels under nondenaturing conditions and assayed for im-2 A normal lymphoblastoid cell line refers to lymphoblasts in long term culture that were derived from a patient who is clinically normal.
Human Hypoxanthine-Guanine Phosphoribosyltransferase munoreactive protein using the protein blot technique. Fig. 1 shows autoradiographs of two representative experiments. Lymphoblast extract from the normal cell lines MGL-8 (Fig. 1A, lane N) , GM 130 (data not shown), and WI-L2 (data not shown) demonstrated one immunoreactive isoelectric species with an isoelectric point equal to 6.0±0.1 (mean±1 SD, n = 3). Several observations indicate that this is HPRT. This band was absent when control antiserum was used in place of anti-HPRT serum or when lymphoblast extract from the cell line GM 467 (<0.1% of control immunoreactive protein) was analyzed (data not shown). In addition, an in situ activity stain of an identical gel demonstrated that HPRT enzyme activity and immunoreactive protein focus at the same pH (data not shown).
The isoelectric point of HPRT from G.S. was identical to normal (Fig. 1A, lane GS) . In contrast, the isoelectric points of the enzymes from I.V. (Fig. LA , lane IV) and E.S. (Fig. 1A , lane ES) were increased from the normal value of 6.0 to 6.4 and 6.2, respectively, while the isoelectric point of the enzyme from L.P. (Fig. 1A, inary study of the lymphoblast extract from T.C. demonstrated a faint band of immunoreactive protein that focused at pH 5.85 (Fig. 1A, lane TC) . Repeated experiments indicated that the enzymes from the siblings T.C. (Fig. 1B, lane TC) and K.C. (Fig. 1B , lane KC) were indistinguishable from one another and were indeed more acidic than the normal enzyme (Fig. 1B,  lane N) . However, the enzymes from T.C. and K.C. were not as acidic as the enzyme from L.P. (Fig. 1B,  lane LP) .
Nondenaturing polyacrylamide gel electrophoresis of lymphoblast HPRT. Membrane-free extracts from normal and HPRT-deficient lymphoblasts were fractionated under nondenaturing conditions in polyacrylamide slab gels and the HPRT enzymes were detected immunochemically using the protein blot technique. An autoradiograph of a representative protein blot is shown in Fig. 2 . Lymphoblast extract from a normal cell line (MGL-8) demonstrated one immunoreactive protein band (Fig. 2, lane N) . Careful inspection of the autoradiograph revealed that this rather broad band is composed of three closely spaced bands. This microheterogeneity is most likely due to noncovalent interactions since the lymphoblast enzyme has only one detectable isoelectric species (see Fig. 1 ). The identification of this band as HPRT was suggested by the following: (a) the band was absent when control rabbit serum was used in place of rabbit HPRT anti- lymphoblastoid cell line (GM 467) with undetectable HPRT immunoreactive protein (<0.1% of control) did not demonstrate this protein band (Fig. 2, lane GM) ; and (c) this band of immunoreactive protein comigrated with an area of HPRT enzyme activity (see Fig. 3 ).
The enzyme from T.C. (Fig. 2, lane TC) and G.S. (Fig. 2, lane GS) was indistinguishable from normal lymphoblast HPRT. In contrast, HPRT from L.P. (Fig.  2, lane LP) exhibited a more anodal migration while HPRT from I.V. (Fig. 2, lane IV) and from E.S. (Fig.  2, lane ES) exhibited a more cathodal migration. The migration of enzyme from I.V. was consistantly slightly more cathodal than was the migration of enzyme from E.S.
The HPRT enzymes were also detected by the in situ enzyme activity stain described in Methods. Fig.  3 shows an autoradiograph of a representative activity stain experiment. The radioactive bands in Fig. 3 representing areas of HPRT enzyme activity are, with one exception, coincident with the areas of immunoreactive protein shown in Fig. 2 , thus, supporting the data derived from the protein blot experiments. The one notable exception is HPRT from E.S. The main band of enzyme activity (Fig. 3, lane ES) is slightly more cathodal than that of normal lymphoblast HPRT (Fig.  3, lane N) and is coincident with the single immunoreactive protein band detected by protein blot analysis (Fig. 2, lane ES) . In addition, however, there is a very rapidly migrating band of enzyme activity that does not correspond to any analogous band of immunoreactive protein.
HPRT enzyme activity was virtually undetectable in this lymphoblast extract when measured in the presence of normal concentrations of substrates. This in- FIGURE 3 Activity stain of lymphoblast HPRT after nondenaturing polyacrylamide gel electrophoresis. Lymphoblast extracts were electrophoresed in nondenaturing polyacrylamide gels as described in the legend to Fig. 2 dicates that the rapidly migrating HPRT is most likely an altered molecular form of this patient's kinetically abnormal enzyme rather than a contaminating HPRT from bacteria or mycoplasma. This may, indeed, represent dissociation of the native tetramer (22) to a smaller molecular form (i.e., dimer or monomer) and suggests that the alteration in the primary structure of this variant enzyme may have affected its subunitsubunit interactions. The reason why this rapidly migrating form of HPRT was not detected in the protein blot experiments is unknown. This smaller molecular form may be less immunoreactive than the native tetramer. Alternatively, the enzyme may not transfer efficiently to the nitrocellulose paper from this area of the gel.
Purification of normal and mutant lymphoblast HPRT. HPRT was labeled in culture with [35S]-methionine and purified as described in Methods. Each lymphoblastoid cell line studied had taken up '50% of the total radioactivity in the culture medium (3 X 108 cpm) after 14 h of labeling; one-third of this radioactivity (1 X 108 cpm) was usually found to be incorporated into soluble protein. Labeled HPRT in a normal lymphoblastoid cell line (MGL-8), and in lymphoblasts derived from patients L.P., G.S., and I.V. was isolated in near homogeneous form by a two-step procedure using a heat step and immunoprecipitation. The purified enzyme preparations contained the following total quantities of 35S radioactivity: MGL-8, 45,074±9,431 cpm (mean±1 SD, four purifications); L.P., 17,275±275 cpm (mean±1 SD, three purifications); G.S., 9,546 cpm (one purification); and I.V., 35,600 (average of two purifications). SDS-polyacrylamide gel electrophoresis of these purified enzymes demonstrated one major band of radioactivity (Fig. 4 , lanes N, IV, and LP, and Fig. 5 lane GS) which, in each case, comigrated with the highly purified erythrocyte enzymes from each patient (data not shown). Integration of densitometer scans of these autoradiographs indicated that the enzymes were radiochemically >95% pure (data not shown).
The heat step was omitted from the purification of HPRT in lymphoblasts of patients T.C. and E.S. because these variant enzymes were more labile to heat inactivation than was the normal enzyme (data not shown). The immunoprecipitates from these cell extracts demonstrated numerous 35S-labeled protein bands after SDS-polyacrylamide gel electrophoresis (Fig. 4 , lanes ES, ES', and TC). The specific HPRT protein was identified as the single protein band that competed with excess unlabeled highly purified erythrocyte enzyme for binding to the HPRT antibody during the immunoprecipitation step (Fig. 4, (Fig. 4, lane N) . The apparent molecular weight of HPRT from L.P. (Fig. 4 lane LP) , E.S. (Fig. 4 , lane ES), and T.C. (Fig. 4 lane TC) was indistinguishable from that of the normal lymphoblast enzyme (Fig. 4. lane N) techniques we studied the structure and function of HPRT in lymphoblasts derived from six patients in five unrelated families with a deficiency of this enzyme. The lymphoblast enzymes were compared to each other in terms of their concentration in cell lysates (level of immunoreactive protein), catalytic function (absolute specific activity), isoelectric point, migration during nondenaturing polyacrylamide gel electrophoresis, and apparent subunit molecular weight. These experiments clearly indicated that the lymphoblast enzyme from each HPRT-deficient family studied was indeed a unique structural variant. A summary of these results is provided in Table II . We have recently reported the purification and characterization of HPRT from erythrocytes of these same patients (11) . A detailed study of the function and subunit structure of the highly purified erythrocyte enzymes indicated that four of the enzymes were unique structural variants. These variants were named HPRTToronto (patient L.P.), HPRTLondon (patient G.S.), HPRTMunich (patient I.V.), and HPRTKinston (patient E.S.). As summarized in Table II , the major functional and structural abnormalities detected in these four erythrocyte enzyme variants were similar to those observed for the corresponding lymphoblast enzymes.
An earlier study of the erythrocyte enzyme from the C. family was limited in scope because of the difficulty in obtaining sufficient quantities of the purified enzyme (11) . A limited study of the subunit structure of this purified erythrocyte enzyme failed to detect any structural abnormalities. In the present study, using micromethods of enzyme structural analysis, we clearly demonstrated that HPRT in lymphoblasts derived from T.C. and K.C. has an apparently normal subunit molecular weight and an isoelectric point that is lower than the normal value. Furthermore, this enzyme variant was shown to be electrophoretically distinct from the other known structural variants of HPRT. We therefore suggest that this unique enzyme variant be called HPRTAnn Arbor
The only notable difference between the lymphoblast and erythrocyte enzymes was that none of the lymphoblast enzymes demonstrated the electrophoretic heterogeneity previously reported for the erythrocyte enzymes from these patients. Normal erythrocyte HPRT has been shown to exhibit complex 
